is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Molecular diagnostics and therapeutics is becoming a driving force in drug development. Applications have spread from identifying infections to include screening for cancer, hepatitis, and a variety of genetic disorders, and even tissue screening to minimise the risks of tissue rejection. This conference will discuss recent developments on next-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing and early cancer detection that are having a profound impact on healthcare delivery.
Chair: Dr Naravat Poungvarin, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand
Scientific Adviser: Dr Masafumi Inoue, Senior Research Scientist & Group Leader, Molecular Diagnostics Group, Experimental Therapeutics Centre, Nanos, Singapore
Dr Tho Huu Ho,Vietnam Military Medical University, Hanoi, Vietnam
Dr Lim Pich, National Center for Health Promotion, Ministry of Health, Phnom Penh, Cambodia
Prof Jo Martin, Barts & The London NHS Trust, UK